四维血流MRI评估肝硬化患者静脉曲张风险的验证研究
本研究纳入2022年9月至2023年6月行腹部四维血流MRI的连续患者80例(肝硬化53例、健康27例),分为静脉曲张组、非静脉曲张组和健康组。结果显示主门静脉流速在静脉曲张组为24.81±8.52,高于非静脉曲张组的19.52±5.07和健康组的17.26±5.48;联合主门静脉与脾静脉的流速和血管直径评估静脉曲张风险的AUC为0.83(95%CI 0.72-0.94)。
要点
- 主门静脉流速在静脉曲张组为24.81±8.52,高于非静脉曲张组的19.52±5.07和健康组的17.26±5.48。
- 主门静脉与脾静脉的流速及血管直径在各组间差异有统计学意义(p<0.05)。
- 联合主门静脉和脾静脉的流速与血管直径评估静脉曲张风险AUC为0.83(95%CI 0.72-0.94)。
核心结论
- 联合主门静脉和脾静脉的流速与血管直径可有效预测肝硬化患者静脉曲张的发生。
研究设计与样本
- 研究纳入2022年9月至2023年6月行MRI的连续患者80例(肝硬化53例、健康27例),分为静脉曲张组、非静脉曲张组和健康组,采用方差分析和事后LSD-t检验,血流动力学参数与肝功能分级的相关性采用Kendall相关系数评估。
关键影像表现/征象
- 主门静脉流速在静脉曲张组为24.81±8.52,高于非静脉曲张组的19.52±5.07和健康组的17.26±5.48。
- 主门静脉流速、脾静脉流速及主门静脉血管直径、脾静脉血管直径在各组间差异有统计学意义(p<0.05)。
诊断标准与关键数值
- 联合主门静脉和脾静脉的流速与血管直径评估静脉曲张风险的AUC为0.83(95%CI 0.72-0.94)。
临床应用与阅片要点
- 四维血流MRI可显示肝硬化患者的血流动力学变化,并辅助识别胃食管静脉曲张,作为静脉曲张风险预测的标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aims to validate the application of abdominal four-dimensional flow magnetic resonance imaging (MRI) for cirrhotic patients and quantify its effectiveness in assessing the hemodynamic impacts of cirrhosis to evaluate varices.
METHODS: All consecutive patients who underwent MRIs between September 2022 and June 2023 were enrolled. Groups were divided into varicose, non-varicose, and healthy groups. ANOVA and post hoc LSD-t tests were used for statistical analysis. The correlation between hemodynamic parameters and liver function grade was evaluated using Kendall's correlation coefficient.
RESULTS: A total of 80 patients were included (53 cirrhotic, 27 healthy). Significant disparities were found in main portal vein flow (MPV-FR), splenic vein flow (SV-FR), and vessel diameters (MPV-VD, SV-VD) among the groups (p < 0.05). MPV-FR was higher in the varicose group (24.81 ± 8.52) compared to non-varicose (19.52 ± 5.07) and healthy groups (17.26 ± 5.48). The most robust assessment of variceal risk was achieved by combining the flow rates (FRs) and VDs of MPV and SV (AUC 0.83, 95% CI 0.72-0.94).
CONCLUSION: The combined indices of FRs and VDs of MPV and SV effectively predict the occurrence of varicose veins in cirrhotic patients.
KEY POINTS: Question Non-invasive prediction of variceal risk is essential for the clinical management of advanced chronic cirrhosis, yet existing clinical examinations are inadequate. Findings The effective assessment of variceal risk was achieved by combining the flow rates and vessel diameters of the main portal vein and splenic vein. Clinical relevance Four-dimensional flow MRI can reveal hemodynamic changes in cirrhotic patients and assist in identifying gastroesophageal varices, serving as a marker for varices risk prediction.
引用
- Hu Q, Li G, Zhang D, et al. Assessment of four-dimensional flow MRI for prediction of varices risk in cirrhotic patients. Eur Radiol. 2024. PMID: 39601830. doi:10.1007/s00330-024-11222-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。